ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (747 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0162-0134(97)81617-0    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1997 Published by Elsevier Science B.V.

Tyrosinase-catecholic substrates in Vitro model: kinetic studies on the o-quinone/o-semiquinone radical formation*1

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Rosa Pia Ferraria, Corresponding Author Contact Information, E-mail The Corresponding Author, Enzo Laurentia, 1, Elena Maria Ghibaudia and Luigi Casellab, 2

a Dipartimento di Chimica I.F.M., Università di Torino, Torino, Italy

b Dipartmento di Chimica Generale, Università di Pavia, Pavia, Italy


Received 10 January 1997; 
accepted 5 March 1997. ;
Available online 25 February 1999.

Abstract

The mechanism of o-semiquinone production was examined in the tyrosinase and peroxidase catalyzed oxidations of a series of catecholic compounds using the electron spin resonance (ESR) spin-stabilization approach and in the presence of 3-methyl-2-benzothiazolinone hydrazone (MBTH). In the tyrosinase process, the nonenzymatic o-semiquinone formation by inverse disproportion mechanism was clearly confirmed. Mechanistic and kinetic studies of o-semiquinone and o-quinone formation by mushroom tyrosinase were carried out by ESR spin stabilization and optical spectroscopy. Two different types of cyclizable catecholic substrates (Image -dopa and dopamine 3,4-dihydroxyphenylacetic acid and 3-(3,4-dihydroxyphenyl)propionic acid) together with an uncyclizable substrate (3,4-dihydroxybenzoic acid) were examined. The reactive quinones were monitored by measuring the apparent initial rates of the o-quinone-MBTH adducts. The transient behaviour of the o-semiquinone was studied by determining the pseudo first-order formation constants (k values in the range 0.226–0.035 s−1), the relative second-order decay kinetic constants (k = 3.3·102 M−1 s−1 for dopamine o-semiquinone) and the maximum concentrations of the o-semiquinone complexes formed in situ with Mg2+ ions. The o-semiquinone formation constants are not directly correlated with their maximum concentrations; in fact, the o-semiquinone maximum concentration of the uncyclizable substrate is comparable with that derived from Image -dopa. Furthermore, the secondary semiquinone formation is slow and not competitive with the primary semiquinone generation. Then, in our model the limiting factor for the o-semiquinone formation, is not simply the substrate ability to cyclize, and, therefore, the potential toxicity of the secondary semiquinone is questionable.

Abbreviations: Image -dopa, Image -3,4-dihydroxyphenylalanine; HRP, horseradish peroxidase; MBTH, 3-methyl-2-benzothiazolinone hydrazone; DMAB, 3-dimethylaminobenzoic acid; TEMPO, 2,2,6,6-tetramethylpiperidine-N-oxyl

Article Outline

• References

Corresponding Author Contact InformationCorresponding author. Address correspondence to: Professor Rosa Pia Ferrari, Dipartimento di Chimica I.F.M., Università di Torino, Via P. Giuria 7, 10125 , Torino, , Italy

*1 This research was supported by grants from the Ministero Italiano Università Ricerca Scientifica e Tecnologica (MURST) and from the Comitato Biotecnologie, Consiglio Nazionale Italiano delle Ricerche (CNR).

1 Dr. E. Laurenti received a fellowship from the Fondazione Biotecnologie, Torino.

2 Prof. L. Casella thanks the European Community, through the contract ERBCHRXCT920014, for financial support.


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2009 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.